Dr. Goeminne Sofie
ActiveDr. Goeminne Sofie has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €302k and a net result of €300k. Equity is growing by ~16% per year across the filed fiscal years. Its solvency ranks better than 87% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 13.02 against 19.97 in 2023; short-term debt: 7.2% and cash: 47.5% of total assets), and 7.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
92.8%
Return on assets
92.2%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-07-2025, 1 day ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
not confirmed
2024
1 d early
2023
8 d early
2022
26 d early
2021
17 d early
2020
23 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€302k▲ 20.5%
2023 · €251k
2020: €121k
2021: €276k
2022: €499k
2023: €251k
2020 → 2024
Total assets
€325k▲ 23.4%
2023 · €264k
2020: €157k
2021: €302k
2022: €510k
2023: €264k
2020 → 2024
Net result
€300k▲ 20.6%
2023 · €249k
2020: €119k
2021: €156k
2022: €223k
2023: €249k
2020 → 2024
Working capital
€283k▲ 13.7%
2023 · €249k
2020: €121k
2021: €275k
2022: €496k
2023: €249k
2020 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€121k-€276k▲ 128%€499k▲ 80.4%€251k▼ 49.7%€302k▲ 20.5%
Operating result€153k-€203k▲ 32.6%€292k▲ 43.7%€331k▲ 13.1%€398k▲ 20.4%
Net result€119k-€156k▲ 31.1%€223k▲ 42.9%€249k▲ 11.4%€300k▲ 20.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2024 is 20% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €325k
Fixed assets
€19k▲ 915%
Current assets
€306k▲ 17.0%
Equity and liabilities €325k
Equity
€302k▲ 20.5%
Debt
€24k▲ 79.5%
The debt ratio rises from 5.0% to 7.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€401k▲
2023 · €332k
Cash flow
€303k▲
2023 · €250k
Solvency
92.8%▼
2023 · 95.0%
Current ratio
13.02▼
2023 · 19.97
Quick ratio
13.02▼
2023 · 19.97
Debt / equity
0.08▲
2023 · 0.05
ROE
99.3%▲
2023 · 99.2%
ROA
92.2%▼
2023 · 94.3%
Interest coverage
185.54▲
2023 · 70.51
Debt
€24k▲
2023 · €13k
Debt ≤ 1 year
€24k▲
2023 · €13k
Income taxes
€96k▲
2023 · €78k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€264k€325k▲
Fixed assets21/28€2k€19k▲
Tangible fixed assets22/27€2k€19k▲
Plant, machinery and equipment23€748€428▼
Furniture and vehicles24€1k€19k▲
Current assets29/58€262k€306k▲
Amounts receivable within one year40/41€141k€152k▲
Trade receivables40€133k€152k▲
Other amounts receivable41€7k€167▼
Cash at bank and in hand54/58€121k€155k▲
Equity and liabilities
Total equity and liabilities10/49€264k€325k▲
Equity10/15€251k€302k▲
Contributions10/11€2k€2k=
Reserves13€249k€300k▲
Distributable reserves133€249k€300k▲
Profit (loss) carried forward14-€0
Amounts payable17/49€13k€24k▲
Amounts payable within one year42/48€13k€24k▲
Trade debts44€1k€5k▲
Suppliers440/4€1k€5k▲
Taxes, remuneration and social security45€9k€7k▼
Taxes450/3€9k€7k▼
Other amounts payable47/48€3k€12k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€894€3k▲
Other operating charges640/8€671€4k▲
Gross operating margin9900€332k€405k▲
Operating profit (loss)9901€331k€398k▲
Financial income75/76B€303€167▼
Recurring financial income75€303€167▼
Financial charges65/66B€5k€2k▼
Recurring financial charges65€5k€2k▼
Profit (loss) for the period before taxes9903€326k€396k▲
Income taxes67/77€78k€96k▲
Profit (loss) for the period9904€249k€300k▲
Profit (loss) for the period to be appropriated9905€249k€300k▲
Appropriation of the result
Profit (loss) to be appropriated9906€249k€300k▲
Transfer from equity791/2€497k€249k▼
Transfer to equity691/2€249k€300k▲
To other reserves6921€249k€300k▲
Profit to be distributed694/7€497k€249k▼
Return on contributions (dividend)694€497k€249k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2020net €300k ▲20.6%
Operating result €398k, net result €300k, both a record.
23-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
05-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Liquidity quadruplescurrent ratio 43.53
Current ratio from 11.86 to 43.53; short-term debt falls from €25k to €12k.
14-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity triplescurrent ratio 11.86
Current ratio from 4.38 to 11.86; short-term debt falls from €36k to €25k.
31-12
Financial
Equity above €200kEq €276k ▲128%
2 profitable years in a row build equity to €276k.
08-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Herentals · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Langepad(HRT) 232200 HerentalsGround area
1.0 ha
Building footprint
398 m²
Volume, LiDAR
832 m³
Parcel 13302C0512/00S000, Flanders · tallest building 9.4 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Dr. Goeminne Sofie
since 20202.302.278.766
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13302C0512/00S000 | Flanders | 1.0 ha | 1 · 398 m² | 9.4 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
HASSAN MEDICAL
BE 0877.915.920
Binche · Eq €302k
FM GYNECOLOGIE
BE 0780.646.892
Verviers · Eq €302k
Poliklinieken Solidaris Limburg
BE 0410.518.450
Hasselt · Eq €302k
Dr Julie GOUJON-DUBOIS
BE 0811.667.492
Clavier · Eq €302k
JEROLIST
BE 0808.935.161
Wetteren · Eq €302k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,974. 6,660 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-03-2020
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.